Literature DB >> 22422850

Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results.

J J Kerremans1, H A Verbrugh, M C Vos.   

Abstract

In a prospective observational study of bacteremic patients we ascertained the influence of different parts of culture results on the correctness of empirical antibiotic therapy. Ninety-three bacteremic patients requiring antibiotic treatment were included. Patients who had consultations with an infectious disease consultation service before they became bacteremic received microbiologically correct empirical antibiotic therapy more often than those who did not have such consultations (75% versus 53%; P = 0.03). As a direct result of Gram staining, 92% of all patients received microbiologically correct antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422850      PMCID: PMC3372104          DOI: 10.1128/JCM.06051-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

Authors:  B Byl; P Clevenbergh; F Jacobs; M J Struelens; F Zech; A Kentos; J P Thys
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use.

Authors:  J J Kerremans; P Verboom; T Stijnen; L Hakkaart-van Roijen; W Goessens; H A Verbrugh; M C Vos
Journal:  J Antimicrob Chemother       Date:  2007-12-21       Impact factor: 5.790

4.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

  4 in total
  12 in total

Review 1.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

2.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

3.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

Review 4.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.

Authors:  Jeffrey R Strich; Emily L Heil; Henry Masur
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

6.  Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults.

Authors:  R B Saunderson; T Gouliouris; E K Nickerson; E J P Cartwright; A Kidney; S H Aliyu; N M Brown; D Limmathurotsakul; S J Peacock; M E Török
Journal:  Clin Microbiol Infect       Date:  2015-05-29       Impact factor: 8.067

7.  Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital.

Authors:  H Akhloufi; R H Streefkerk; D C Melles; J E M de Steenwinkel; C A M Schurink; R P Verkooijen; C P van der Hoeven; A Verbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-28       Impact factor: 3.267

8.  Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.

Authors:  Carmen Axente; Monica Licker; Roxana Moldovan; Elena Hogea; Delia Muntean; Florin Horhat; Ovidiu Bedreag; Dorel Sandesc; Marius Papurica; Dorina Dugaesescu; Mirela Voicu; Luminita Baditoiu
Journal:  BMC Infect Dis       Date:  2017-05-22       Impact factor: 3.090

Review 9.  Rapid clinical bacteriology and its future impact.

Authors:  Alex van Belkum; Géraldine Durand; Michel Peyret; Sonia Chatellier; Gilles Zambardi; Jacques Schrenzel; Dee Shortridge; Anette Engelhardt; William Michael Dunne
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

Review 10.  An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors:  Anand Kumar
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.